Nirali N. Shah, M.D., M.H.Sc.

Head, Hematologic Malignancies Section at National Cancer Institute

Dr. Shah leads the Hematologic Malignancies Section at the National Cancer Institute, focusing on hematology and oncology.

Speaking History (1 events)

2026 FDA Cellular, Tissue, and Gene Therapies Advisory Committee Meeting

October 31, 2026